Skip to content

Vivani Medical VANI Neurostimulation Division — Operating Expenses

Other segment segments

Biopharm Division
$6M0.0%
Neuromodulation Division
$800K+33.3%

Similar metrics at other companies

Asset Entities logo
ASSTMedical Device — Operating Expenses
$7.48M
Enovis logo
ENOVPrevention & Recovery — Operating Costs and Expenses
$245.97M+0.1%
electroCore, Inc. logo
ECORBioelectronic Innovations — Operating Expenses
$13.68M+43.6%
MaxCyte logo
MXCTCell Engineering Technology — Operating Expenses
$14.27M-32.7%
Fortive logo
FTVAdvanced Healthcare Solutions — Operating Expenses
-$159M-1.7%
Ormat Technologies logo
ORAEnergy Storage — Segment operating expenses (income)
$13.78M+1,478%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's neurostimulation division — operating expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's neurostimulation division — operating expenses?
Vivani Medical (VANI) reported neurostimulation division — operating expenses of $650K in Q4 2025.
What does neurostimulation division — operating expenses mean?
Represents the total costs incurred by the neurostimulation business segment to support its day-to-day operations. This includes all functional expenditures such as labor, facilities, and administrative costs necessary to maintain the segment's ongoing activities. Monitoring this metric helps investors assess the operational burn rate and cost structure of the division.